Snyder Capital Management L P Purchases 20,087 Shares of STERIS plc (NYSE:STE)

Snyder Capital Management L P grew its stake in shares of STERIS plc (NYSE:STE - Free Report) by 15.7% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 148,384 shares of the medical equipment provider's stock after buying an additional 20,087 shares during the quarter. Snyder Capital Management L P owned 0.15% of STERIS worth $30,502,000 at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. Norges Bank purchased a new stake in shares of STERIS during the fourth quarter worth about $238,836,000. Raymond James Financial Inc. purchased a new stake in STERIS in the fourth quarter worth approximately $223,987,000. Franklin Resources Inc. boosted its holdings in STERIS by 171.2% in the third quarter. Franklin Resources Inc. now owns 838,569 shares of the medical equipment provider's stock worth $191,370,000 after purchasing an additional 529,308 shares during the last quarter. Wellington Management Group LLP boosted its stake in shares of STERIS by 4,534.6% during the 4th quarter. Wellington Management Group LLP now owns 219,032 shares of the medical equipment provider's stock worth $45,024,000 after acquiring an additional 214,306 shares during the last quarter. Finally, Boston Trust Walden Corp lifted its stake in shares of STERIS by 400.4% during the 4th quarter. Boston Trust Walden Corp now owns 224,741 shares of the medical equipment provider's stock valued at $46,198,000 after buying an additional 179,829 shares in the last quarter. Institutional investors own 94.69% of the company's stock.

Analysts Set New Price Targets

A number of analysts have issued reports on STE shares. Piper Sandler lifted their price target on shares of STERIS from $260.00 to $265.00 and gave the company an "overweight" rating in a report on Monday, February 3rd. Stephens reiterated an "overweight" rating and issued a $240.00 price target on shares of STERIS in a report on Thursday, February 6th. JMP Securities restated a "market outperform" rating and set a $265.00 target price on shares of STERIS in a research note on Thursday, April 10th. Finally, Needham & Company LLC reissued a "hold" rating on shares of STERIS in a report on Monday, April 7th. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. According to MarketBeat.com, STERIS presently has an average rating of "Moderate Buy" and a consensus price target of $258.75.

STERIS Price Performance

STE traded up $0.26 during midday trading on Monday, reaching $225.26. 610,377 shares of the company's stock were exchanged, compared to its average volume of 526,408. The business's 50-day moving average price is $222.89 and its 200 day moving average price is $218.85. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.13 and a quick ratio of 1.40. The stock has a market capitalization of $22.13 billion, a PE ratio of 47.83 and a beta of 0.87. STERIS plc has a 1-year low of $200.98 and a 1-year high of $248.24.

STERIS (NYSE:STE - Get Free Report) last issued its earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. As a group, equities analysts anticipate that STERIS plc will post 9.08 EPS for the current fiscal year.

STERIS Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, March 21st. Investors of record on Thursday, February 20th were paid a $0.57 dividend. The ex-dividend date of this dividend was Thursday, February 20th. This represents a $2.28 dividend on an annualized basis and a yield of 1.01%. STERIS's dividend payout ratio is currently 48.41%.

STERIS Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.